CURRENT RESEARCH STUDIES

Type II Diabetes (28264)

COR Clinical Research is evaluating an investigational medication for patients with Type II diabetes. Patients that qualify will receive an FDA approved diabetes medication at no charge. Study duration is 22 weeks and would require 18 visits.

Entry Qualifications:

  1. Be 18 years or older.
  2. Have Type II Diabetes for at least 3 months.
  3. Be on Metformin and either sulfonylurea (such as glipizide, gliclazide, glyburide, or gliquidone) or a TZD (Avandia, Actos).
  4. Seeking better control of blood glucose levels.

Participants that qualify will receive study-related care, lab tests, and study medication at no charge. If you would like more information, or are interested in participating in this study please contact COR Clinical Research at (405) 272-8481.

Please call us at 405-272-8481 for more information, and please mention our website.